Molecular dynamics simulations and novel drug discovery

X Liu, D Shi, S Zhou, H Liu, H Liu… - Expert opinion on drug …, 2018 - Taylor & Francis
Introduction: Molecular dynamics (MD) simulations can provide not only plentiful dynamical
structural information on biomacromolecules but also a wealth of energetic information …

The importance of ongoing international surveillance for Creutzfeldt–Jakob disease

N Watson, JP Brandel, A Green, P Hermann… - Nature Reviews …, 2021 - nature.com
Creutzfeldt–Jakob disease (CJD) is a rapidly progressive, fatal and transmissible
neurodegenerative disease associated with the accumulation of misfolded prion protein in …

Extracellular vesicles–propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases

N Vassileff, L Cheng, AF Hill - Journal of Cell Science, 2020 - journals.biologists.com
Neurodegenerative diseases are characterised by the irreversible degeneration of neurons
in the central or peripheral nervous systems. These include amyotrophic lateral sclerosis …

Neuroimaging in dementia

AM Staffaroni, FM Elahi, D McDermott… - Seminars in …, 2017 - thieme-connect.com
Although the diagnosis of dementia still is primarily based on clinical criteria, neuroimaging
is playing an increasingly important role. This is in large part due to advances in techniques …

Genetic PrP prion diseases

MO Kim, LT Takada, K Wong… - Cold Spring …, 2018 - cshperspectives.cshlp.org
Genetic prion diseases (gPrDs) caused by mutations in the prion protein gene (PRNP) have
been classified as genetic Creutzfeldt–Jakob disease, Gerstmann–Sträussler–Scheinker …

Age at onset in genetic prion disease and the design of preventive clinical trials

EV Minikel, SM Vallabh, MC Orseth, JP Brandel… - Neurology, 2019 - AAN Enterprises
Objective To determine whether preventive trials in genetic prion disease could be designed
to follow presymptomatic mutation carriers to onset of disease. Methods We assembled age …

[HTML][HTML] Genetic counseling for prion disease: updates and best practices

JS Goldman, SM Vallabh - Genetics in Medicine, 2022 - Elsevier
Prion disease is a rare, fatal, and often rapidly progressive neurodegenerative disease. Ten
to fifteen percent of cases are caused by autosomal dominant gain-of-function variants in the …

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases

M Schmitz, A Villar-Piqué, P Hermann, G Escaramís… - Brain, 2022 - academic.oup.com
Genetic prion diseases are a rare and diverse group of fatal neurodegenerative disorders
caused by pathogenic sequence variations in the prion protein gene, PRNP. Data on CSF …

Fatal familial insomnia and sporadic fatal insomnia

L Cracco, BS Appleby, P Gambetti - Handbook of clinical neurology, 2018 - Elsevier
Fatal familial insomnia (FFI) and sporadic fatal insomnia (sFI), or thalamic form of sporadic
Creutzfeldt–Jakob disease MM2 (sCJDMM2T), are prion diseases originally named and …

Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease

SM Vallabh, EV Minikel, VJ Williams, BC Carlyle… - BMC medicine, 2020 - Springer
Background Prion disease is neurodegenerative disease that is typically fatal within months
of first symptoms. Clinical trials in this rapidly declining symptomatic patient population have …